[ad_1]
The Trump administration launched its new TrumpRx prescription drug itemizing web site late Thursday, a part of a push by President Trump to supply decrease direct-to-consumer drug costs.
The president struck offers final yr with greater than a dozen drugmakers to record a few of their medicine on TrumpRx at steep reductions from record costs, with megacompanies like Pfizer and Novo Nordisk — recognized for weight reduction and diabetes medicine Ozempic and Wegovy — signing on.
The positioning lists dozens of prescribed drugs at lowered charges. For instance, a four-week provide of Wegovy injection pens is listed at $199 for the primary two months and $349 after that, properly beneath the record value of $1,349.02. Novo Nordisk has supplied Wegovy for equally discounted costs by way of its NovoCare Pharmacy program in current weeks.
A unit of Gonal-F, a typical drug used as a part of the in vitro fertilization (IVF) course of, is listed on TrumpRx at $252, an 83% low cost from the sticker value. Mr. Trump pledged on the marketing campaign path to make sure that fertility therapies are absolutely coated both by non-public insurance coverage or the federal government.
The positioning doesn’t promote medicine straight — as a substitute, customers are prompted to print out a gold-embossed coupon that it says can be utilized at pharmacies.
In a White Home occasion Thursday night, Mr. Trump referred to as it “one of the vital transformative well being care initiatives of all time.” The administration’s Chief Design Officer Joe Gebbia, an Airbnb founder who helped design the location, mentioned extra medicine can be added to TrumpRx over time.
It isn’t clear how a lot of an impression TrumpRx could have on the costs most People pay for prescribed drugs.
Most individuals pay for his or her medicine by way of insurance coverage somewhat than out-of-pocket, so the reductions supplied by TrumpRx might not change what they pay. The positioning notes: “In case you have insurance coverage, examine your co-pay first—it might be even decrease.”
“The direct-to-patient stuff is, in my opinion, a sideshow and branding alternative for Trump,” Sean Sullivan, a well being economist on the College of Washington, advised CBS Information final yr. “Most sufferers have drug protection. … Only a few are going to purchase medicines with money, until the drug just isn’t a coated profit, like weight reduction or erectile dysfunction medicine.”
However steeply discounted direct-to-consumer choices may matter for uninsured People, folks with excessive deductibles and sufferers whose medicines aren’t coated by their insurance coverage — together with some customers of weight reduction and IVF medicine.
“You shouldn’t be shopping for medicine anymore, going ahead, with out no less than checking to see if these medicines can be found at these discounted costs,” Dr. Mehmet Oz, the administrator of the Facilities for Medicare and Medicaid Companies, mentioned Thursday.
Mr. Trump has pressed drugmakers for months to slash their costs.
Past TrumpRx, he has lower offers with a number of pharmaceutical firms to supply their medicine to Medicaid sufferers at most-favored-nation costs, that means they can’t cost greater than the costs paid by folks in different high-income nations. The businesses additionally agreed to supply most-favored-nation pricing for brand new medicine launched within the U.S.
The truth that People are likely to pay far increased drug costs than their European friends has lengthy vexed members of each events. For years, lawmakers have proposed capping U.S. drug costs or tying them to the costs paid in overseas nations, although pharmaceutical firms have usually pushed again, warning that value caps may make it more durable to pay for analysis into new medicine.
“People have lengthy been paying the best drug costs anyplace on the earth whereas different nations usually paid pennies on the greenback for the very same medicine,” the president mentioned Thursday. “We had been primarily subsidizing the complete world.”
Pharmaceutical firms routinely increase costs originally of every yr, and 2026 has been no exception, drug pricing specialists advised CBS Information.
Producers raised record costs of 947 brand-name medicine this January, whereas reducing costs on 20, in response to drug pricing analysis nonprofit 46brooklyn. The record costs for brand-name medicine — that are just like the sticker costs set by drugmakers earlier than rebates or different reductions are negotiated — elevated by a median of 4% to date in 2026, on par with final yr’s improve.
The dimensions of annual will increase has fallen within the final decade amid public backlash over excessive drug prices, however final yr’s will increase nonetheless outpaced the inflation price.
Information from 46brooklyn does present that in just a few instances, record costs for extensively used medicine have fallen considerably. The record value of Eliquis, a blood thinner, plunged 43%, whereas Jardiance, used to deal with Kind 2 diabetes, fell 44%. Each medicine had been among the many first 10 medicines chosen for Medicare value negotiations by way of a Biden-era provision within the Inflation Discount Act.
The Client Value Index for prescribed drugs — which tracks transaction prices somewhat than record costs — has additionally risen 2% between December 2024 and December 2025. And since January 2025, when Mr. Trump was inaugurated for his second time period, the index has declined by lower than 1%.
[ad_2]
